全文获取类型
收费全文 | 21568篇 |
免费 | 2978篇 |
国内免费 | 472篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 365篇 |
妇产科学 | 292篇 |
基础医学 | 882篇 |
口腔科学 | 268篇 |
临床医学 | 4457篇 |
内科学 | 2399篇 |
皮肤病学 | 304篇 |
神经病学 | 858篇 |
特种医学 | 502篇 |
外国民族医学 | 1篇 |
外科学 | 1492篇 |
综合类 | 1955篇 |
一般理论 | 4篇 |
预防医学 | 3672篇 |
眼科学 | 245篇 |
药学 | 5325篇 |
50篇 | |
中国医学 | 1327篇 |
肿瘤学 | 513篇 |
出版年
2024年 | 79篇 |
2023年 | 728篇 |
2022年 | 800篇 |
2021年 | 1481篇 |
2020年 | 1534篇 |
2019年 | 1390篇 |
2018年 | 1320篇 |
2017年 | 1297篇 |
2016年 | 1225篇 |
2015年 | 1160篇 |
2014年 | 1831篇 |
2013年 | 2359篇 |
2012年 | 1510篇 |
2011年 | 1332篇 |
2010年 | 1075篇 |
2009年 | 958篇 |
2008年 | 842篇 |
2007年 | 766篇 |
2006年 | 694篇 |
2005年 | 553篇 |
2004年 | 376篇 |
2003年 | 294篇 |
2002年 | 281篇 |
2001年 | 228篇 |
2000年 | 153篇 |
1999年 | 100篇 |
1998年 | 108篇 |
1997年 | 66篇 |
1996年 | 85篇 |
1995年 | 63篇 |
1994年 | 44篇 |
1993年 | 30篇 |
1992年 | 49篇 |
1991年 | 31篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 17篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 29 毫秒
11.
12.
《Vaccine》2020,38(19):3582-3590
BackgroundConcern about adverse events following immunization is frequently cited by both those who receive or decline vaccines. Neurological adverse events are especially concerning.ObjectivesOur aim was to detect associations between seasonal influenza vaccination and the occurrence of severe anesthesia/paresthesia or severe headaches.MethodsData were analyzed from the Canadian National Vaccine Safety network. Events occuring on days 0–7 were self-reported and prevented daily activity, led to school or work absenteeism, or required medical attention. Controls were the previous year’s vaccinees; events in controls were collected prior to the start of the influenza vaccination program of each year (2012/13 through 2016/17). Multivariable logistic regression was used to determine the association between seasonal influenza vaccination and the occurrence of anesthesia/paresthesia or severe headaches.ResultsThe total sample was 107,565 for investigating anesthesia/paresthesia and 97,420 for investigating severe headaches. Anesthesia/paresthesia was reported by 104/107,565 (0.10%) participants; 63/69,129 (0.09%) vaccinees and 41/38,436 (0.11%) controls (adjusted odds ratio (aOR) = 0.89; 95% CI = 0.60, 1.32). Severe headaches were reported by 1361/97,420 (1.40%) participants; 907/61,463 (1.48%) vaccinees and 454/35,957 (1.26%) controls (aOR = 1.21; 95% CI = 1.08, 1.36). No specific vaccine product was associated with severe headaches.ConclusionsOur study found no association between severe anesthesia/paresthesia and seasonal influenza vaccination. While there was an association with severe headaches as an adverse event following influenza vaccination, the rates of these events are similar to rates reported from clinical trials and are not a cause for additional concern. 相似文献
13.
14.
15.
《Vaccine》2016,34(20):2349-2353
BackgroundIn October 2011, the Advisory Committee on Immunization Practices (ACIP) issued updated recommendations that all pregnant women routinely receive a dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.ObjectivesWe characterized reports to the Vaccine Adverse Event Reporting System (VAERS) in pregnant women who received Tdap after this updated recommendation (2011–2015) and compared the pattern of adverse events (AEs) with the period before the updated recommendation (2005–2010).MethodsWe searched the VAERS database for reports of AEs in pregnant women who received Tdap vaccine after the routine recommendation (11/01/2011–6/30/2015) and compared it to published data before the routine Tdap recommendation (01/01/2005–06/30/2010). We conducted clinical review of reports and available medical records. The clinical pattern of reports in the post-recommendation period was compared with the pattern before the routine Tdap recommendation.ResultsWe found 392 reports of Tdap vaccination after the routine recommendation. One neonatal death but no maternal deaths were reported. No maternal or neonatal deaths were reported before the recommendation. We observed an increase in proportion of reports for stillbirths (1.5–2.8%) and injection site reactions/arm pain (4.5–11.9%) after the recommendation compared to the period before the routine recommendation for Tdap during pregnancy. We noted a decrease in reports of spontaneous abortion (16.7–1%). After the 2011 Tdap recommendation, in most reports, vaccination (79%) occurred during the third trimester compared to 4% before the 2011 Tdap recommendation. Twenty-six reports of repeat Tdap were received in VAERS; 13 did not report an AE. One medical facility accounted for 27% of all submitted reports.ConclusionsNo new or unexpected vaccine AEs were noted among pregnant women who received Tdap after routine recommendations for maternal Tdap vaccination. Changes in reporting patterns would be expected, given the broader use of Tdap in pregnant women in the third trimester. 相似文献
16.
17.
青光眼是致盲的主要原因之一,构成视神经的神经节细胞轴突受到多种因素的损伤,其机制尚未完全明了。青光眼最重要的危险因素是眼压升高。由于青光眼的视神经损伤尚不能直接治疗,根据目前提供的唯一已知可治疗的危险因素,可以降低升高的眼压,而眼压与房水流出通道的功能息息相关。这些方面的药物均可以影响青光眼的进展。随着医疗技术的发展以及对青光眼发病机制认识的加深,新型抗青光眼药物也应运而生,为眼科医师提供新的选择。本文将对国内外新型抗青光眼药物从机制、药理特点及临床疗效等方面进行综述。 相似文献
18.
19.
20.